Privia Health raises 2025 outlook with 32% adjusted EBITDA growth target amid value-based care expansion [Seeking Alpha]
Privia Health Group, Inc. (PRVA)
Company Research
Source: Seeking Alpha
Parth Mehrotra, CEO, highlighted strong execution across all aspects of the business, emphasizing that "Privia Health's consistent results, operational execution and differentiated business model have clearly demonstrated our ability to perform in all Quick Insights The Evolent ACO acquisition is expected to add over 120,000 value-based care attributed lives and contribute positively to adjusted EBITDA in 2026 through cross-sell synergies and performance improvements, but full benefits may take several years to materialize. Provider growth, value-based attribution, higher utilization in new markets, and margin expansion are the primary drivers of increases in practice collections (up 27.1%) and adjusted EBITDA (up 61.6%), with continued focus on operational execution and diversified contracts. Potential risks include capitation challenges in Medicare Advantage, integration of the Evolent ACO deal, MSSP baseline resets, and regulatory changes, but the company mitigates exposur
Show less
Read more
Impact Snapshot
Event Time:
PRVA
Last Price
Price Change
Price Change%
Volume Shares
Max Up
Max Down
%
Volume Ratio
Performance Comparison
Updated
|
Event Day
Stock performance from the time of news release until the following 4pm ET market close
|
Last price at news event
|
Since Event
Multi-day stock performance from the time of the news release
|
|---|---|---|
|
EVENT DAY
Stock performance from the time of news release until the following 4pm ET market close
|
LAST
PRICE AT NEWS EVENT |
SINCE EVENT
Multi-day stock performance from the time of the news release
|
| Last Price | ||
| VWAP | ||
|
High:
|
Max Up |
High:
|
|
Low:
|
Max Down |
Low:
|
|
%
|
Post news range |
%
|
|
|
Price change |
|
|
|
Price Change Percentage |
|
|
|
S&P 500 (SPX) |
|
|
%
|
Volume ratio |
%
|
| Volume | ||
| Ticks | ||
|
|
Avg transaction size |
|
Don't Miss Out On The Next BIG Stock Move
Event day
Event Day Chart will not be displayed beyond 90-day period of the event
Performance since event
Time And Velocity Analysis
Be the first to know
Opt in for alerts from News Quantifed
Sign Up Today
Opt-in for
PRVA alerts
Learn More With NQ
Reading the Impact Report
Help Me Understand This Data
Help Me Understand This Data
How NQ Works
What is news-based trading?
And why is it so successful?
And why is it so successful?
Movers & Shakers
The biggest gainers and losers and WHY it moved
PRVA alerts
High impacting Privia Health Group, Inc. news events
Weekly update
A roundup of the hottest topics
PRVA
News
- Privia Health Group (NASDAQ:PRVA) had its "overweight" rating reaffirmed by analysts at Stephens. They now have a $32.00 price target on the stock.MarketBeat
- How Recent Developments Are Shaping the Investment Story for Privia Health [Yahoo! Finance]Yahoo! Finance
- A Look at Privia Health Group's (PRVA) Valuation Following Strong Q3 Results and Cautious Guidance [Yahoo! Finance]Yahoo! Finance
- Privia Health Group (NASDAQ:PRVA) had its "hold (c)" rating reaffirmed by analysts at <a style="font-weight:bold" href="https://weissratings.com/">Weiss Ratings</a>.MarketBeat
- Healthcare Technology for Providers Q3 Earnings: Privia Health (NASDAQ:PRVA) is the Best in the Biz [Yahoo! Finance]Yahoo! Finance
PRVA
Earnings
- 11/6/25 - Beat
PRVA
Sec Filings
- 11/6/25 - Form S-3ASR
- 11/6/25 - Form 10-Q
- 11/6/25 - Form 8-K
- PRVA's page on the SEC website